Authors : Dharmesh Trivedi, Anju Goyal
DOI : 10.18231/j.ijpca.2020.014
Volume : 7
Issue : 2
Year : 2020
Page No : 87-97
Dexketoprofen Trometamol is a NSAID, used as an analgesic and anti-inflammatory drug. It works by
blocking the action of cyclo-oxygenase in the body. Conventional route of delivery has many drawbacks
such as hepatic first-pass metabolism, reduced bioavailability, and fluctuating drug concentrations in the
blood. These problems can be overcome by development of transdermal drug delivery system. The objective
of this study was to develop and evaluate the transdermal patches of the drug Dexketoprofen Trometamol.
The patches were prepared by solvent casting method using polymers; Ethyl cellulose, HPMC and ERS
100 in different ratios.
The prepared formulations were uniform in their physical characteristics. The formulation F6, combination
of polymer (HPMC: EC in ratio 4:1) showed maximum release of 85.77% in 24 hours. The resultant data
was fitted in to zero, first, Higuchi and Peppas model. The results specify that Dexketoprofen Trometamol
transdermal patch can be designed for obtaining better therapeutic benefits.
Keywords: Transdermal drug delivery system, TDDS, Skin patches, Kinetics, NSAIDs, Analgesic, Invitro and exvivo drug release.